1. Loscalzo J. Harrison's Cardiovascular Medicine 2/E. 3rd Ed. New York: McGraw-Hill Education; 2013.
2. Nelson LS, Hoffman RS, Howland MA, Lewin NA, Goldfrank LR. Goldfrank's toxicologic emergencies. New York: McGraw Hill Professional; 2018.
3. Hoffman J. Incidence, mortality and natural history. In: Anderson RH, Macortney FJ, Shinebourne EA. All pediatric cardiology. London: Churchill Livinstone; 1997.
4. Sharma Sh, Kaur N, Kaur Kh, Pawar NCh. Role of echocardiography in prenatal screening of congenital heart diseases and its correlation with postnatal outcome. J Clin Diagn Res 2017; 11: TC12-TC14. [
DOI:10.7860/JCDR/2017/25929.9750] [
PMID] [
PMCID]
5. Buskens E, Grobbee DE, Frohn-Mulder IM, Wladimiroff JW, Hess J. Aspects of the aetiology of congenital heart disease. Eur Heart J 1995; 16: 584-587. [
DOI:10.1093/oxfordjournals.eurheartj.a060960] [
PMID]
6. Hoffman RS, Howland MA, Lewin NA, Nelson LS, Goldfrank LR. Goldfrank's toxicologic emergencies. New York: McGraw Hill Professional; 2014.
7. Hunter LE, Seale AN. Educational series in congenital heart disease: Prenatal diagnosis of congenital heart disease. Echo Res Pract 2018; 5: R81-R100. [
DOI:10.1530/ERP-18-0027] [
PMID] [
PMCID]
8. Chu Ch, Yan Y, Ren Y, Li X, Gui Y. Prenatal diagnosis of congenital heart diseases by fetal echocardiography in second trimester: A Chinese multicenter study. Acta Obstet Gynecol Scand 2017; 96: 454-463. [
DOI:10.1111/aogs.13085] [
PMID]
9. Alves deRocha L, Júnior EA, Marcondes Machado Nardozz L, Fernandes Moron A. Screening of fetal congenital heart disease: The challenge continues. Rev Bras Cir Cardiovasc 2013; 28: V-VII. [
DOI:10.5935/1678-9741.20130048] [
PMID]
10. Fouron JC, Proulx F, Miró J, Gosselin J. Doppler and M-mode ultrasonography to time fetal atrial and ventricular contractions. Obstet Gynecol 2000; 96: 732-736.
https://doi.org/10.1097/00006250-200011000-00016 [
DOI:10.1016/S0029-7844(00)01007-3] [
PMID]
11. Jaeggi E, Fouron JC, Fournier A, van Doesburg N, Drblik SP, Proulx F. Ventriculo-atrial time interval measured on M-mode echocardiography: A determining element in diagnosis, treatment, and prognosis of fetal supraventricular tachycardia. Heart 1998; 79: 582-587. [
DOI:10.1136/hrt.79.6.582] [
PMID] [
PMCID]
12. Mosaed P. Fetal echocardiography; Introduction and approaches. Sarem J Reprod Med 2018; 2: 31-34. [
DOI:10.29252/sjrm.2.1.31]
13. Nayak K, Naveen Chandra GS, Shetty R, Narayan PK. Evaluation of fetal echocardiography as a routine antenatal screening tool for detection of congenital heart disease. Cardiovasc Diagn Ther 2016; 6: 44-49.
14. Barsoom MJ, Feldman DM, Borgida AF, Esters D, Diana D, Egan J. Is an isolated fetal cardiac echogenic focus an indication for fetal echocardiography? J Ultrasound Med 2001; 20: 1043-1046. [
DOI:10.7863/jum.2001.20.10.1043] [
PMID]
15. Ghiasi SS, Mottaghi Moghaddam Shahri H, Heidari E. Fetal echocardiography indications: A single-center experience. Int J Pediatr 2019; 7: 8969-8976.
16. Chitra N, Vijayalakshmi IB. Fetal echocardiography for early detection of congenital heart diseases. J Echocardiogr 2017; 15: 13-17. [
DOI:10.1007/s12574-016-0308-2] [
PMID]
17. Rakha S, El Marsafawy H. Sensitivity, specificity, and accuracy of fetal echocardiography for high-risk pregnancies in a tertiary center in Egypt. Arch Pédiatr 2019; 26: 337-341. [
DOI:10.1016/j.arcped.2019.08.001] [
PMID]
18. Stümpflen I, Stümpflen A, Wimmer M, Bernaschek G. Effect of detailed fetal echocardiography as part of routine prenatal ultrasonographic screening on detection of congenital heart disease. Lancet 1996; 348: 854-857.
https://doi.org/10.1016/S0140-6736(96)04069-X [
DOI:10.1016/S0140-6736(05)65853-9]